Hepatitis Monthly

Published by: Kowsar

Simple and Reliable Method to Quantify the Hepatitis B Viral Load and Replicative Capacity in Liver Tissue and Blood Leukocytes

Claudia Minosse 1 , Sabrina Coen 1 , Ubaldo Visco Comandini 2 , Raffaella Lionetti 2 , Marzia Montalbano 2 , Stefano Cerilli 2 , Donatella Vincenti 1 , Andrea Baiocchini 3 , Maria R. Capobianchi 1 and Stefano Menzo 4 , *
Authors Information
1 Laboratory of Virology, National Institute for Infectious Diseases “L. Spallanzani”, Rome, Italy
2 Liver Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, Italy
3 Laboratory of Pathology, National Institute for Infectious Diseases “L. Spallanzani”, Rome, Italy
4 Laboratory of Virology, Marche Polytechnic University, Ancona, Italy
Article information
  • Hepatitis Monthly: October 01, 2016, 16 (10); e28751
  • Published Online: February 29, 2016
  • Article Type: Research Article
  • Received: March 18, 2015
  • Revised: July 17, 2015
  • Accepted: August 12, 2015
  • DOI: 10.5812/hepatmon.28751

To Cite: Minosse C, Coen S, Visco Comandini U, Lionetti R, Montalbano M, et al. Simple and Reliable Method to Quantify the Hepatitis B Viral Load and Replicative Capacity in Liver Tissue and Blood Leukocytes, Hepat Mon. 2016 ;16(10):e28751. doi: 10.5812/hepatmon.28751.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology. 2006; 131(6): 1743-51[DOI][PubMed]
  • 2. Maynard M, Parvaz P, Durantel S, Chevallier M, Chevallier P, Lot M, et al. Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure. J Hepatol. 2005; 42(2): 279-81[DOI][PubMed]
  • 3. Hadziyannis SJ, Sevastianos V, Rapti I, Vassilopoulos D, Hadziyannis E. Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir. Gastroenterology. 2012; 143(3): 629-36 e1[DOI][PubMed]
  • 4. Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science. 2014; 343(6176): 1221-8[DOI][PubMed]
  • 5. Zeisel MB, Lucifora J, Mason WS, Sureau C, Beck J, Levrero M, et al. Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure. Gut. 2015; 64(8): 1314-26[DOI][PubMed]
  • 6. Brunetto MR, Moriconi F, Bonino F, Lau GK, Farci P, Yurdaydin C, et al. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology. 2009; 49(4): 1141-50[DOI][PubMed]
  • 7. Manesis EK, Papatheodoridis GV, Tiniakos DG, Hadziyannis ES, Agelopoulou OP, Syminelaki T, et al. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B. J Hepatol. 2011; 55(1): 61-8[DOI][PubMed]
  • 8. Wong DKH, Seto WK, Fung J, Ip P, Huang FY, Lai CL, et al. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos (t) ide analogues of different potency. Clin Gastroenterol Hepatol. 2013; 11(8): 1004-1010. e1
  • 9. Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell. 47(3): 451-60[DOI]
  • 10. Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015; 479-480: 672-86[DOI][PubMed]
  • 11. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology. 2004; 126(7): 1750-8[PubMed]
  • 12. Sung JJ, Wong ML, Bowden S, Liew CT, Hui AY, Wong VW, et al. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology. 2005; 128(7): 1890-7[PubMed]
  • 13. Bourne EJ, Dienstag JL, Lopez VA, Sander TJ, Longlet JM, Hall JG, et al. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy. J Viral Hepat. 2007; 14(1): 55-63[DOI][PubMed]
  • 14. Mazet-Wagner AA, Baclet MC, Loustaud-Ratti V, Denis F, Alain S. Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients. J Virol Methods. 2006; 138(1-2): 70-9[DOI][PubMed]
  • 15. Stoll-Becker S, Repp R, Glebe D, Schaefer S, Kreuder J, Kann M, et al. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol. 1997; 71(7): 5399-407[PubMed]
  • 16. Cabrerizo M, Bartolome J, Caramelo C, Barril G, Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology. 2000; 32(1): 116-23[DOI][PubMed]
  • 17. Umeda M, Marusawa H, Seno H, Katsurada A, Nabeshima M, Egawa H, et al. Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers. J Hepatol. 2005; 42(6): 806-12[DOI][PubMed]
  • 18. Wong DK, Yuen MF, Yuan H, Sum SS, Hui CK, Hall J, et al. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology. 2004; 40(3): 727-37[DOI][PubMed]
  • 19. Singh M, Dicaire A, Wakil AE, Luscombe C, Sacks SL. Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR. J Virol Methods. 2004; 118(2): 159-67[DOI][PubMed]
  • 20. Taranta A, Tien Sy B, Zacher BJ, Rogalska-Taranta M, Manns MP, Bock CT, et al. Hepatitis B virus DNA quantification with the three-in-one (3io) method allows accurate single-step differentiation of total HBV DNA and cccDNA in biopsy-size liver samples. J Clin Virol. 2014; 60(4): 354-60[DOI][PubMed]
  • 21. He ML, Wu J, Chen Y, Lin MC, Lau GK, Kung HF. A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. Biochem Biophys Res Commun. 2002; 295(5): 1102-7[PubMed]
  • 22. Reaiche GY, Le Mire MF, Mason WS, Jilbert AR. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Virology. 2010; 406(2): 286-92[DOI][PubMed]
  • 23. Guo Y, Sheng S, Nie B, Tu Z. Development of magnetic capture hybridization and quantitative polymerase chain reaction for hepatitis B virus covalently closed circular DNA. Hepat Mon. 2015; 15(1)[DOI][PubMed]
  • 24. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol. 2003; 21(21): 3902-8[DOI][PubMed]
  • 25. Loustaud-Ratti V, Wagner A, Carrier P, Marczuk V, Chemin I, Lunel F, et al. Distribution of total DNA and cccDNA in serum and PBMCs may reflect the HBV immune status in HBsAg+ and HBsAg- patients coinfected or not with HIV or HCV. Clin Res Hepatol Gastroenterol. 2013; 37(4): 373-83[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments